University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor

Igor J. Barani, M.D.

Radiation cancer specialist

Dr. Igor Barani is a radiation cancer specialist with a particular interest in the treatment of cancer of the brain and central nervous system. He specializes in the use of radiosurgical techniques, such as the Cyberknife, to treat adults and children with malignant and benign conditions. He's also interested in the development and implementation of new treatments for brain tumors, especially treatments that preserve brain and other neurologic function.

Barani's research revolves around neural stem cells and their potential roles in the development of gliomas, which is cancer of the brain or spine, as well as neurocognitive decline after treatment. The study of treatment-related side effects is increasingly important as the number of long-term survivors of childhood and adult brain tumors increases with improved therapies. Barani is exploring neural stem cell biology and modern treatment techniques to benefit patients with central nervous system tumors. He is an assistant professor of radiation oncology at UCSF.

Conditions & Treatments

Clinics

Radiation Oncology at Parnassus
505 Parnassus Ave, Room L-75
San Francisco, CA 94143-0226
Phone: (415) 353-8335
Fax: (415) 353-7281

Hours: Monday to Friday
8 a.m. – 4:30 p.m.

More about Igor J. Barani

Education

SUNY, Syracuse School of Medicine 2003

Residencies

Virginia Commonwealth University School of Medicine, Radiation Oncology 2008

Selected Research and Publications

  1. Descovich M, Ma L, Chuang CF, Larson DA, Barani IJ. Comparison between prone and supine patient setup for spine stereotactic body radiosurgery. Technol Cancer Res Treat. 2012 Jun; 11(3):229-36.
  2. Caballero JA, Sneed PK, Lamborn KR, Ma L, Denduluri S, Nakamura JL, Barani IJ, McDermott MW. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy. Int J Radiat Oncol Biol Phys. 2012 May 1; 83(1):303-9.
  3. Ma L, Lee L, Barani I, Hwang A, Fogh S, Nakamura J, McDermott M, Sneed P, Larson DA, Sahgal A. Shot sequencing based on biological equivalent dose considerations for multiple isocenter Gamma Knife radiosurgery. Phys Med Biol. 2011 Nov 21; 56(22):7247-56.
  4. Bloch O, Kaur G, Jian BJ, Parsa AT, Barani IJ. Stereotactic radiosurgery for benign meningiomas. J Neurooncol. 2012 Mar; 107(1):13-20.
  5. Lupo JM, Chuang CF, Chang SM, Barani IJ, Jimenez B, Hess CP, Nelson SJ. 7-tesla susceptibility-weighted imaging to assess the effects of radiotherapy on normal-appearing brain in patients with glioma. Int J Radiat Oncol Biol Phys. 2012 Mar 1; 82(3):e493-500.
  6. Kirby N, Chuang C, Pouliot J, Hwang A, Barani IJ. Physics strategies for sparing neural stem cells during whole-brain radiation treatments. Med Phys. 2011 Oct; 38(10):5338-44.
  7. Rutkowski MJ, Bloch O, Jian BJ, Chen C, Sughrue ME, Tihan T, Barani IJ, Berger MS, McDermott MW, Parsa AT. Management of recurrent intracranial hemangiopericytoma. J Clin Neurosci. 2011 Nov; 18(11):1500-4.
  8. Rutkowski MJ, Jian BJ, Bloch O, Chen C, Sughrue ME, Tihan T, Barani IJ, Berger MS, McDermott MW, Parsa AT. Intracranial hemangiopericytoma: Clinical experience and treatment considerations in a modern series of 40 adult patients. Cancer. 2012 Mar 15; 118(6):1628-36.
  9. Ma L, Sahgal A, Hwang A, Hu W, Descovich M, Chuang C, Barani I, Sneed PK, McDermott M, Larson DA. A two-step optimization method for improving multiple brain lesion treatments with robotic radiosurgery. Technol Cancer Res Treat. 2011 Aug; 10(4):331-8.
  10. Tate M, Sughrue ME, Rutkowski MJ, Kane AJ, Aranda D, McClinton L, McClinton L, Barani IJ, Parsa AT. The long-term postsurgical prognosis of patients with pineoblastoma. Cancer. 2012 Jan 1; 118(1):173-9.
  11. Todor DA, Barani IJ, Lin PS, Anscher MS. Moving toward focal therapy in prostate cancer: dual-isotope permanent seed implants as a possible solution. Int J Radiat Oncol Biol Phys. 2011 Sep 1; 81(1):297-304.
  12. Sughrue ME, Choi J, Rutkowski MJ, Aranda D, Kane AJ, Barani IJ, Parsa AT. Clinical features and post-surgical outcome of patients with astroblastoma. J Clin Neurosci. 2011 Jun; 18(6):750-4.
  13. Ma L, Petti P, Wang B, Descovich M, Chuang C, Barani IJ, Kunwar S, Shrieve DC, Sahgal A, Larson DA. Apparatus dependence of normal brain tissue dose in stereotactic radiosurgery for multiple brain metastases. J Neurosurg. 2011 Jun; 114(6):1580-4.
  14. Dasgupta T, Barani IJ, Roach M. Successful radiation treatment of anaplastic thyroid carcinoma metastatic to the right cardiac atrium and ventricle in a pacemaker-dependent patient. Radiat Oncol. 2011; 6:16.
  15. Descovich M, Sneed PK, Barbaro NM, McDermott MW, Chuang CF, Barani IJ, Nakamura JL, Lijun M. A dosimetric comparison between Gamma Knife and CyberKnife treatment plans for trigeminal neuralgia. J Neurosurg. 2010 Dec; 113 Suppl:199-206.
  16. Ivan ME, Sughrue ME, Clark AJ, Kane AJ, Aranda D, Barani IJ, Parsa AT. A meta-analysis of tumor control rates and treatment-related morbidity for patients with glomus jugulare tumors. J Neurosurg. 2011 May; 114(5):1299-305.
  17. Kane AJ, Sughrue ME, Rutkowski MJ, Aranda D, Mills SA, Buencamino R, Fang S, Barani IJ, Parsa AT. Posttreatment prognosis of patients with esthesioneuroblastoma. J Neurosurg. 2010 Aug; 113(2):340-51.
  18. Rutkowski MJ, Sughrue ME, Kane AJ, Aranda D, Mills SA, Barani IJ, Parsa AT. Predictors of mortality following treatment of intracranial hemangiopericytoma. J Neurosurg. 2010 Aug; 113(2):333-9.
  19. Sughrue ME, Yang I, Kane AJ, Fang S, Clark AJ, Aranda D, Barani IJ, Parsa AT. Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma. J Neurooncol. 2011 Feb; 101(3):463-76.
  20. Sahgal A, Barani IJ, Novotny J, Zhang B, Petti P, Larson DA, Ma L. Prescription dose guideline based on physical criterion for multiple metastatic brain tumors treated with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2010 Oct 1; 78(2):605-8.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.